Targeted therapy for Wilms tumor: a bibliometric study of worldwide scientific activity and collaborative networks

针对威尔姆斯肿瘤的靶向治疗:全球科学活动和合作网络的文献计量学研究

阅读:1

Abstract

BACKGROUND AND PURPOSE: Wilms tumor (WT), or nephroblastoma, is the most common abdominal solid tumor in children with a recurrence rate as high as 15%. Targeted therapy is an effective treatment choice for patients with WT. This study aimed to evaluate the global research activity and collaborative networks of WT targeted therapy through the bibliometric analysis. METHODS: The Web of Science Core Collection (WoSCC) database was used to search related studies on targeted therapy for WT published between 1945 and 2024. Subsequently, the VOSviewer, Graphpad, and Bibliometrix package in the R Studio were applied to conduct bibliometric and visualized analysis. RESULTS: A total of 1,604 publications were included in our analysis. The USA (n = 572) took the dominant position in the number of publications and Harvard University contributed most papers (n = 122). Sugiyama H and Oka Y demonstrated superior performance in this domain, with Sugiyama H leading in the number of publications (n = 59) and Oka Y leading in terms of co-citations (n = 382). The most productive journal was the Oncogene (n = 44). "Expression" and "Wilms Tumor" were the most frequent keywords, while "lncRNA", "Biomarkers" and "microRNA" were recent hotspots. CONCLUSIONS: Research on targeted therapy for WT has developed rapidly with increasing interests, which emphasizes its growing importance in the scientific community. Nonetheless, the primary research has been primarily concentrated in a limited number of developed regions, and global collaboration remains inadequate. International collaborations and translational research should be reinforced to facilitate further advancements in this field.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。